LNTH at a 25% discount is pretty cheap. They have
Post# of 148184
They have done their homework, buyout out a cash negative corp.
Again, the only reason, is to quietly and under the radar increase their market share of Leronlomab.
I, myself, was looking for a chance to get into PGNX. But with this new and LNTH drop, couldn't help myself but to buy that.
All IMO.